Knowstox

Fundamentals snapshot

Lam Research Corporation

LRCX · NMS · Technology · Semiconductor Equipment & Materials

Current price

$307.65

52-week range

$104.46 - $438.50

Market cap

$384.97B

One-glance verdict

Overvalued

$81.64 our estimate vs market $307.65

Wall Street consensus: $370.87 (354.3% higher than our fair-value estimate)

Balance sheet

Healthy

52.27x Strong cushion

Net cash $1.46B. Interest coverage shows how many times profit covers the interest bill.

What this company does

Lam Research Corporation

Lam Research builds and sells the complex, high-tech machinery that other companies use to manufacture the tiny computer chips found in phones, computers, and cars. The company makes its money primarily from selling these essential machines and providing services for them. This is important because as the world demands more and more powerful electronics, the need for Lam's specialized chip-making tools grows, making it a critical supplier in the global technology supply chain (the network of businesses that get a product from idea to customer).

Price history

How the share price has moved

Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2025 Q1 $1.46B FY2025 Q2 $553.59M FY2025 Q3 $1.02B FY2025 Q4 $2.38B FY2026 Q1 $1.59B FY2026 Q2 $1.22B FY2026 Q3 $809.82M FY2026 Q4 $1.27B
Revenue $6.72B
Net income $2.28B
Diluted EPS 1.81
Operating cash flow $1.46B
Free cash flow $1.27B
Revenue $5.84B
Net income $1.83B
Diluted EPS 1.45
Operating cash flow $1.14B
Free cash flow $809.82M
Revenue $5.34B
Net income $1.59B
Diluted EPS 1.26
Operating cash flow $1.48B
Free cash flow $1.22B
Revenue $5.32B
Net income $1.57B
Diluted EPS 1.24
Operating cash flow $1.78B
Free cash flow $1.59B
Revenue $5.17B
Net income $1.72B
Diluted EPS 1.34
Operating cash flow $2.55B
Free cash flow $2.38B
Revenue $4.72B
Net income $1.33B
Diluted EPS 1.03
Operating cash flow $1.31B
Free cash flow $1.02B
Revenue $4.38B
Net income $1.19B
Diluted EPS 0.92
Operating cash flow $741.94M
Free cash flow $553.59M
Revenue $4.17B
Net income $1.12B
Diluted EPS 0.86
Operating cash flow $1.57B
Free cash flow $1.46B

Is it cheap or expensive?

Fair value $81.64 vs current price $307.65

Wall Street consensus is the average analyst price target: $370.87 (354.3% higher than our fair-value estimate).

Our most-likely fair value is $81.64 a share — about 73.5% below today's price of $307.65, so the stock currently looks expensive (overvalued).

overvalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 15.0% · Discount 12.1% · Terminal 2.5%

$81.64

Bear

Growth 2.5% · Discount 12.1% · Terminal 2.5%

$43.11

Bull

Growth 25.0% · Discount 12.1% · Terminal 2.5%

$134.70

Is it drowning in debt?

Healthy

Net cash $1.5B - more cash than debt. Interest coverage 52.3x.

Net debt $-1.46B
Interest coverage 52.27x

Lam Research Corporation's profit covers its interest bill about 52.3 times over. which is stronger than most peers shown here.

Healthy
Worse cushion Baseline Better cushion
LRCX BASELINE Lam Research Corporation

Total debt $4.12B Interest coverage 52.27x This is the baseline the peer rows are being compared against.

Total debt $7.35B Interest coverage 31.49x -40% vs LRCX Carries about 1.7x less debt cushion than LRCX.

Total debt $2.31B Interest coverage 95.53x +83% vs LRCX Carries about 1.8x more debt cushion than LRCX.

Total debt $6.15B Interest coverage 19.90x -62% vs LRCX Carries about 2.6x less debt cushion than LRCX.

Total debt $0.00 Interest coverage 313.72x +500% vs LRCX Carries about 6.0x more debt cushion than LRCX.

Total debt $81.92M Interest coverage 1,042.33x +1,894% vs LRCX Carries about 19.9x more debt cushion than LRCX.

What you should know

The case for and against LRCX

3 Rewards 1 Risk

Rewards

  • Revenue grew 26.0% last year.
  • Returns 65.1% on equity, ahead of 66% of its peers.
  • Free cash flow was positive in 10/10 years.

Risks

  • Stock trades 38.3% above its 5-year average P/E.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
53.50x
Forward P/E
26.58x
P/B
30.87x
P/S
16.57x
EV/EBITDA
44.38x
PEG ratio
1.43x

Profitability

How much profit each dollar creates

Gross margin
50.5%
Operating margin
37.4%
Net margin
31.3%
ROE
65.1%
ROA
22.8%

Health

Liquidity and balance-sheet strength

Debt / equity
0.33x
Current ratio
2.63x
Quick ratio
1.84x
Total debt
$4.12B
Total cash
$5.58B

Growth

How the business has been compounding

Revenue TTM
$23.23B
Revenue 5Y CAGR
7.8%
EPS TTM
5.75
EPS 5Y CAGR
20.1%

Cash flow

How much cash the business throws off

Operating CF TTM
$5.86B
Free CF TTM
$4.89B
FCF margin
21.1%

Dividend

Shareholder payout

Yield
0.4%
Payout ratio
18.1%
Last ex-div date
2026-09-23